DK146194C - Fremgangsmaade til fremstilling af et fast stof indeholdende et eller flere hydrogenerede meldroejealkaloider - Google Patents

Fremgangsmaade til fremstilling af et fast stof indeholdende et eller flere hydrogenerede meldroejealkaloider

Info

Publication number
DK146194C
DK146194C DK454176A DK454176A DK146194C DK 146194 C DK146194 C DK 146194C DK 454176 A DK454176 A DK 454176A DK 454176 A DK454176 A DK 454176A DK 146194 C DK146194 C DK 146194C
Authority
DK
Denmark
Prior art keywords
alcoaloids
hydrogenerated
procedure
preparation
solid substance
Prior art date
Application number
DK454176A
Other languages
English (en)
Other versions
DK146194B (da
DK454176A (da
Inventor
Lothar Ehrhardt
Volker Hartmann
Ludwig Patt
Karl-Heinz Otto
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK454176A publication Critical patent/DK454176A/da
Publication of DK146194B publication Critical patent/DK146194B/da
Application granted granted Critical
Publication of DK146194C publication Critical patent/DK146194C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK454176A 1975-10-17 1976-10-08 Fremgangsmaade til fremstilling af et fast stof indeholdende et eller flere hydrogenerede meldroejealkaloider DK146194C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2546577 1975-10-17
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (3)

Publication Number Publication Date
DK454176A DK454176A (da) 1977-04-18
DK146194B DK146194B (da) 1983-07-25
DK146194C true DK146194C (da) 1984-01-02

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
DK454176A DK146194C (da) 1975-10-17 1976-10-08 Fremgangsmaade til fremstilling af et fast stof indeholdende et eller flere hydrogenerede meldroejealkaloider

Country Status (28)

Country Link
JP (1) JPS5854122B2 (da)
AT (1) AT362510B (da)
AU (1) AU508628B2 (da)
BE (1) BE847368A (da)
CA (1) CA1079641A (da)
CH (1) CH643737A5 (da)
CS (1) CS199647B2 (da)
DE (1) DE2546577B2 (da)
DK (1) DK146194C (da)
ES (1) ES452420A1 (da)
FI (1) FI762875A (da)
FR (1) FR2327764A1 (da)
GB (1) GB1560406A (da)
GR (1) GR61268B (da)
HK (1) HK3183A (da)
HU (1) HU172533B (da)
IE (1) IE43778B1 (da)
IL (1) IL50686A (da)
MY (1) MY8400063A (da)
NL (1) NL184558C (da)
NO (1) NO144468C (da)
NZ (1) NZ182341A (da)
PH (1) PH14513A (da)
PT (1) PT65719B (da)
SE (1) SE430379B (da)
SG (1) SG63082G (da)
SU (1) SU1165223A3 (da)
ZA (1) ZA766166B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
ATE72111T1 (de) * 1987-01-14 1992-02-15 Ciba Geigy Ag Therapeutisches system fuer schwerloesliche wirkstoffe.
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (de) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimal freisetzende Kava-Extrakte
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
MY126580A (en) * 1997-12-22 2006-10-31 Merck Sharp & Dohme Molecular dispersion composition with enchanced bioavailabity
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
ES2236017T3 (es) * 1999-12-03 2005-07-16 Polichem S.A. Procedimientos para la prepaaraciones farmaceuticas de liberacion sostenida de alcaloides del ergot que tienen biodfisponibilidad mejorada y composiciones de los mismos.
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US20060141038A1 (en) * 2003-06-27 2006-06-29 Bioprogress S. P. A. Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2 pyrrolidone/vinyl-acetate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
DE2546577A1 (de) 1977-04-21
AT362510B (de) 1981-05-25
SE7611189L (sv) 1977-04-18
NL184558C (nl) 1989-09-01
FR2327764B1 (da) 1979-03-02
AU508628B2 (en) 1980-03-27
SG63082G (en) 1983-09-09
ATA767976A (de) 1980-10-15
HK3183A (en) 1983-01-20
PT65719A (fr) 1976-11-01
SE430379B (sv) 1983-11-14
NO144468C (no) 1981-09-09
SU1165223A3 (ru) 1985-06-30
AU1875476A (en) 1978-04-20
PT65719B (fr) 1978-06-12
IL50686A (en) 1979-05-31
JPS5854122B2 (ja) 1983-12-02
NZ182341A (en) 1978-09-20
NL7611295A (nl) 1977-04-19
FR2327764A1 (fr) 1977-05-13
GR61268B (en) 1978-10-17
CS199647B2 (en) 1980-07-31
NL184558B (nl) 1989-04-03
CA1079641A (en) 1980-06-17
PH14513A (en) 1981-08-24
MY8400063A (en) 1984-12-31
HU172533B (hu) 1978-09-28
DK146194B (da) 1983-07-25
ES452420A1 (es) 1978-04-16
NO144468B (no) 1981-06-01
DE2546577B2 (de) 1981-04-02
DK454176A (da) 1977-04-18
IL50686A0 (en) 1976-12-31
CH643737A5 (en) 1984-06-29
GB1560406A (en) 1980-02-06
ZA766166B (en) 1978-05-30
IE43778B1 (en) 1981-05-20
JPS5251014A (en) 1977-04-23
NO763446L (da) 1977-04-19
FI762875A (da) 1977-04-18
BE847368A (fr) 1977-04-15
IE43778L (en) 1977-04-17

Similar Documents

Publication Publication Date Title
DK148907C (da) Analogifremgangsmaade til fremstilling af dihydrocyclosporin c
DK424476A (da) Fremgangsmade til fremstilling af svovlholdige organosiliciumforbindelser
DK484876A (da) Fremgangsmade til fremstilling af 2-phenyl-3-aroylbenzothiophener og -thiophen-1-oxider
DK146194C (da) Fremgangsmaade til fremstilling af et fast stof indeholdende et eller flere hydrogenerede meldroejealkaloider
DK113676A (da) Fremgangsmade til fremstilling af et retardpreparat
DK570176A (da) Fremgangsmade til fremstilling af antitumorigene stoffer
DK593975A (da) Fremgangsmade til fremstilling af substituerede perhalogenalkylamidiner
DK163977A (da) Fremgangsmade til fremstilling af et antibiotisk stof
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK227276A (da) Fremgangsmade til fremstilling af olieabsorberende materialer
DK535476A (da) Fremgangsmade til fremstilling af 7-methoxycephalosporiner
DK150676A (da) Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
DK148139C (da) Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK151176A (da) Fremgangsmade til fremstilling af termoplastiske stobeblandinger
DK146629C (da) Analogifremgangsmaade til fremstilling af depotsteroidestere
DK497476A (da) Fremgangsmade til fremstilling af et antibiotisk stof
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK415576A (da) Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK484676A (da) Fremgangsmade til fremstilling af aroyl-phenyliden- eller aroyl-phenylnaphthalenforbindelser
DK536076A (da) Fremgangsmade til syntese af n-methylurinstoffer
DK141584C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK424676A (da) Fremgangsmade til fremstilling af 2-alkylindan
DK480676A (da) Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater
DK526676A (da) Fremgangsmade til fremstilling af 4-chlor-2-butynyl-m-chlorcarbanilat
DK401476A (da) Fremgangsmade til fremstilling af benzocycloheptapyridinforbindelser

Legal Events

Date Code Title Description
PBP Patent lapsed